Immune Response to Hepatitis B Vaccine in Asthmatic Children

Pediatric Pulmonology

Volumn 36, Issue 6, 2003, Pages 522-528

  Masten, Barbara ^a   McWilliams, Bennie ^a   Lipscomb, Mary ^a   Archibeque, Teressa ^a   Qualls, Clifford ^a   Kelly, H William ^b   Schuyler, Mark ^a,c  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CYTOKINE; GAMMA INTERFERON; HEPATITIS B VACCINE; INTERLEUKIN 4; INTERLEUKIN 5; METHACHOLINE; NEDOCROMIL; PLACEBO; STEROID;

ANTIBODY DETECTION; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEPATITIS B; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY; TREATMENT OUTCOME; VACCINATION; VIRUS HEPATITIS;

ADMINISTRATION, INHALATION; ANTI-INFLAMMATORY AGENTS; ASTHMA; BUDESONIDE; CHILD; CHILD, PRESCHOOL; CYTOKINES; DRUG INTERACTIONS; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; MALE; NEDOCROMIL;

EID: 0346328358     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10362     Document Type: Article

References (30)

1. Seaton A, Godden DJ, Brown K. Increase in asthma: a more toxic environment or a more susceptible population? Thorax 1994;49:171-174.
2. Woolcock AJ, Peat JK. Evidence for the increase in asthma worldwide. Ciba Found Symp 1997;206:122-134.
3. Weiss S. Asthma: epidemiology. In: Fishman AP, Elias J, Fishman JA, Grippi A, Kaiser LR, Senior RM, editors. Fishman's pulmonary diseases and disorders. New York: McGraw-Hill; 1998. p 735-743.
4. Romagnani S. Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol 1994;6:838-846.
5. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282:2258-2261.
6. Schuyler M, Lyons CR, Masten B, Bice D. Immunoglobulin response to intrapulmonary immunization of asthmatics. Immunology 1997;91:167-175.
7. Group TCAMPR. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000;343:1054-1063.
8. National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma. Publication no. 97-4051. Bethesda, MD: National Institutes of Health; 1997.
9. Claman HN. Corticosteroids as immunomodulators. Ann NY Acad Sci 1993;685:288-292.
10. Editorial: Tuberculosis in corticosteroid-treated asthmatics. Br Med J 1976;2:266-267.
11. Abzug MJ, Cotton MF. Severe chickenpox after intranasal use of corticosteroids. J Pediatr 1993;123:577-579.
12. Shaikh WA. Pulmonary tuberculosis in patients treated with inhaled beclomethasone. Allergy 1992;47:327-330.
13. SAS/STAT. Statistical analysis, version 8.0. Cary, NC: SAS Institute; 1999. p 1465-1636.
14. Umetsu DT, Leung DY, Siraganian R, Jabara HH, Geha RS. Differential requirements of B cells from normal and allergic subjects for the induction of IgE synthesis by an alloreactive T cell clone. J Exp Med 1985;162:202-214.
15. Kay AB. Advances in immunology: allergy and allergic diseases. N Engl J Med 2001;344:30-37.
16. Finkelman FD. Relationships among antigen presentation, cytokines immune deviation and autoimmune disease. J Exp Med 1995;182:279-282.
17. Umetsu DT, DeKruyff RH. TH1 and TH2 CD4+ cells in human allergic diseases. J Allergy Clin Immunol 1997;100:1-6.
18. Izurieta HS, Strebel PM, Blake PA. Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. JAMA 1997;278:1495-1499.
19. Girsh LS, Yu M, Jones J, Schulaner FA. A study of the risk of mortality of varicella in patients with bronchial asthma or other allergic disease receiving corticosteroid therapy. Ann Allergy 1966;24:690-693.
20. Falliers CJ, Ellis EF. Corticosteroids and varicella. Six-year experience in an asthmatic population. Arch Dis Child 1965;40:593-599.
21. Katz Y, Harbeck R, DiMichelle D, Strunk R. Steroid-treated asthmatic patients with low levels of IgG have a normal capacity to produce specific antibodies. Pediatr Asthma Allergy Immunol 1988;2:309-315.
22. Ishizaka A, Sakiyama Y, Nakanishi M, Tomizawa K, Oshika E, Kojima K, et al. The inductive effect of interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes. Clin Exp Immunol 1990;79:392-396.
23. Spiegelberg HL, Falkoff RJ, Beck L. Interleukin-4 induced IgE and IgG4 secretion by B cells from atopic dermatitis patients. Int Arch Allergy Appl Immunol 1991;94:181-183.
24. Schmitt E, Hoehn P, Germann T, Rude E. Differential effects of interleukin-12 on the development of naive mouse CD4+ T cells. Eur J Immunol 1994;24:343-347.
25. Garraud O, Nkenfou C, Bradley JE, Perler FB, Nutman TB. Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies. J Immunol 1995;155:1316-1325.
26. Ishizaka A, Joh K, Shibata R, Wagatsuma Y, Nakanishi M, Tomizawa K, et al. Regulation of IgE and IgG4 synthesis in patients with hyper IgE syndrome. Immunology 1990;70:414-416.
27. Secrist, H, Chelen CJ, Wen Y, Marshall, JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993;178:2123-2130.
28. Imada M, Simons FE, Jay FT, HayGlass KT. Antigen mediated and polyclonal stimulation of human cytokine production elicit qualitatively different patterns of cytokine gene expression. Int Immunol 1995;7:229-237.
29. Marshall JD, Wen Y, Abrams JS, Umetsu DT. In vitro synthesis of IL-4 by human CD4+ T cells requires repeated antigenic stimulation. Cell Immunol 1993;152:18-34.
30. Holt PG. Key factors in the development of asthma: atopy. Am J Respir Crit Care Med 2000;161:172-175.